Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
letter
. 2020 Jul 10;268(1):1–4. doi: 10.1007/s00415-020-10063-7

Telemedicine for neuromuscular disorders during the COVID-19 outbreak

Matteo Garibaldi 1,, Gabriele Siciliano 2, Giovanni Antonini 1
PMCID: PMC7348562  PMID: 32651671

Dear Sirs,

Telemedicine (TM), whose potential use in disasters and public health emergencies has been highlighted in recent years [1], is now a worldwide rapidly emerging approach for outpatient care in pandemic era [2, 3]. During the COVID-19 outbreak, the volume of elective or non-urgent outpatient cares has significantly been reduced in many centers to limit infection exposure to patients, communities and medical staff, reserving face-to-face consultations to clinical relapses, emergencies or hospital therapies. In this context, TM has been widely proposed as one of the best alternatives for ambulatory clinical practice during quarantine [4].

Studies across the vast array of neurological disorders have reported the role of TM in providing access to neurologic care to people, otherwise limited by geographic or physical barriers [5]. During the COVID-19 lockdown, several neurological societies and independent study groups have developed documents for care delivery to patients affected by neurological and, in particular, neuromuscular diseases (NMD), highlighting the need of new clinical structures including robust telemedicine platforms and procedures to care for NMD patients [6]. Noteworthy, most NMD are chronic, slowly progressive and usually managed in outpatient care services, which makes these disorders particularly suitable for TM. However, remote clinical evaluation can have some important limitations. First of all, while TM assessment appears appropriate for NMD patients with known diagnosis and fairly stable clinical condition, it loses power when used for diagnostic purposes, given the difficulties to appreciate subtle neurological signs, such as mild weakness or sensory deficits. Furthermore, patient’s difficulties to access the teleconsultation and the necessity of a caregiver for TM evaluation for some patients should be considered. Finally, clinical data obtained by TM could not be easily compared to those recorded during ambulatory visits. In this scenario, the use of clinical scales suitable to be administered via TM could help in NMD patient follow-up. An ideal scale for TM should be concise, easy to be administered, reproducible, comprehensive enough in capturing the wide range of different clinical manifestations and informative in remote evaluation of functions without direct clinical examination.

Facing the problem of TM consulting for NMD during COVID-19 outbreak, we suggest, as suitable for that, the following scales: ALSFR-R for motor neuron diseases [7], MG-ADL for neuromuscular junction diseases [8], Myo-FRS for myopathies and Nerve-FRS (N-FRS) for neuropathies. ALSFR-R and MG-ADL are disease-specific scales validated for amyotrophic lateral sclerosis and myasthenia gravis, respectively; they appear the most reliable scales for a remote evaluation in these two disorders, as they satisfy the aforementioned prerogatives required in a TM context and in addition, they allow to compare the score obtained by TM with those previously obtained. Their use could be also extended to other motor neuron diseases and myasthenic syndromes, for which, other disease-specific scales could have some limitations by TM. Validated scales for myopathies and neuropathies are quite disease-specific and difficult to use in remote consultation due to a number of predominantly examiner-dependent items. Accordingly, we conceived the Myo-FRS and the N-FRS, two functional scales, which, rather than explore too much disease-specific tasks, are aimed to capture, basically through a functional questionnaire, the overall characteristics of neuromuscular performance, both in myopathies and in neuropathies (Table 1). MYO-FRS and N-FRS have never been used before, and do not allow a comparison with formerly collected clinical data. However, they provide a practical and useful tool to assign a functional score, which reflects the overall neuromuscular impairment along the disease course. Certainly, time has to come for their validation, but in this historical moment, implementation of routine tests is urgently needed for a homogeneous and effective approach to NMD through TM.

Table 1.

Myo-FRS and N-FRS scales

Myo-FRS N-FRS
1. Ocular

4 Normal

3 Eyelid ptosis

2 Mild ophthalmoparesis (diplopia in one direction)

1 Moderate ophthalmoparesis (diplopia in ≥ 2 directions)

0 Complete ophtalmoplegia (or diplopia in front side)

1. Swallowing

4 Normal

3 Early eating problems (occasional choking with normal eating habits)

2 Dietary consistency changes

1 Advanced eating problems (frequent choking after dietary consistency changes)

0 Needs tube feeding

2. Swallowing

4 Normal

3 Early eating problems (occasional choking with normal eating habits)

2 Dietary consistency changes

1 Advanced eating problems (frequent choking after dietary consistency changes)

0 Needs tube feeding

2. Respiration

4 Normal

3 Dyspnea only with sustained activities (ADL, walking, climbing stairs) and/or mild orthopnoea (> 1 pillow)

2 Dyspnea at rest or moderate-severe orthopnoea (sleep only sitting)

1 Needs of BiPAP (frequent choking after dietary consistency changes)

0 Invasive mechanical ventilation (intubation or tracheostomy)

3. Respiration

4 Normal

3 Dyspnea only with sustained activities (ADL, walking, climbing stairs) and/or mild orthopnoea (> 1 pillow)

2 Dyspnea at rest or moderate-severe orthopnoea (sleep only sitting)

1 Needs of BiPAP (frequent choking after dietary consistency changes)

0 Invasive mechanical ventilation (intubation or tracheostomy)

3. Walking

4 Normal

3 Slow or mild unsteadiness (without aid)

2 Use of unilateral support

1 Use of bilateral support on assistive device

0 Wheelchair dependent

4. Walking

4 Normal

3 Slow or mild difficulties (without aid)

2 Use of unilateral support

1 Use of bilateral support on assistive device

0 Wheelchair dependent

4. Standing up

4 Normal (possible from the floor)

3 With some aid form the floor (but without aid from a chaise)

2 With substitute motions from the chaise (leaning forward, rocking) but without use of arms

2 Requires use of arms from a chaise

1 requires assistance from a device or person

0 Unable to stand

5. Standing up

4 Normal (possible from the floor)

3 With some aid form the floor (but without aid from a chaise)

2 With substitute motions from the chaise (leaning forward, rocking) but without use of arms

2 Requires use of arms from a chaise

1 requires assistance from a device or person

0 Unable to stand

5. Dressing and hygiene

4 Normal

3 Independent but with increased effort or decreased efficiency

2 Intermittent assistance or use substitute methods

1 Needs assistance from caregiver for self-care

0 Total dependence

6. Dressing and hygiene

4 Normal

3 Independent but with increased effort or decreased efficiency

2 Intermittent assistance or use substitute methods

1 Needs assistance from caregiver for self-care

0 Total dependence

6. Rough motor tasks (comb hair, brush teeth, store on top shelf)

4 Normal

3 Independent but extra-effort needed

2 Intermittent assistance or use substitute methods

1 Needs assistance

0 Unable

7. Rough motor tasks (comb hair, brush teeth, store on top shelf)

4 Normal

3 Independent but extra-effort needed

2 Intermittent assistance or use substitute methods

1 Needs assistance

0 Unable

7. Fine motor tasks (using keys, utensils, cutlery)

4 Independent

3 Slow or clumsy but no help needed

2 Independent but requires modified techniques or assistive devices

1 Frequently requires assistance from caregiver

0 Unable or requires total assistance

8. Fine motor tasks (using keys, utensils, cutlery)

4 Independent

3 Slow or clumsy but no help needed

2 Independent but requires modified techniques or assistive devices

1 Frequently requires assistance from caregiver

0 Unable or requires total assistance

8. Turning in bed and adjusting covers

4 Normal

3 Somewhat slow and clumsy but no help needed

2 Can turn alone or adjust sheets, but with great difficulty

1 Can initiate, but not turn or adjust sheets alone

0 Unable or requires total assistance

9. Turning in bed and adjusting covers

4 Normal

3 Somewhat slow and clumsy but no help needed

2 Can turn alone or adjust sheets, but with great difficulty

1 Can initiate, but not turn or adjust sheets alone0 Unable or requires total assistance

9. Autonomic

a. hyper/hypohydration

b. bowel dysfunction

c. bladder/sexual dysfunction

d. orthostatic vertigo/syncope

4 Normal

3 1 domain affected

2 2 domains affected

1 3 domains affected

0 4 domains affected

10. Fatigue in daily living activities

4 Normal

3 Extra effort needed, but no rest periods are needed

2 Rest periods needed

1 Only minimal house-hold activities are performed

0 Total assistance

10. Hypoesthesia, Paraesthesia or Dysesthesia

4 Normal

3 Minimal distal extremities (fingertips)

2 Mild distal extremities (up to ankle/wrist)

1 Moderate distal extremities (up to knee/elbow)

0 Severe diffuse

11. Myalgia

4 Normal

3 Only after sustained activities

2 After slight activities

1 Intermittent at rest

0 Constantly present at rest

11. Pain (NRS scale)

4 0

3 1–3

2 4–6

1 7–9

0 10

Myo-FRS score from 0 (severe disability) to 44 (normal functions), Nerve-FRS score from 0 (severe disability) to 44 (normal functions), NRS numerical rating score (0 = absent, 10 = worst imaginable)

Compliance with ethical standards

Conflicts of interest

All authors report no relevant disclosures and conflict of interest for this study.

Ethical standard

This study has been performed in accordance with the ethical stadards requirements

Contributor Information

Matteo Garibaldi, Email: matteo.garibaldi@uniroma1.it.

Gabriele Siciliano, Email: gabriele.siciliano@unipi.it.

Giovanni Antonini, Email: giovanni.antonini@uniroma1.it.

References

  • 1.Lurie N, Carr BG. The role of telehealth in the medical response to disasters. JAMA Internal Med. 2018;178:745–746. doi: 10.1001/jamainternmed.2018.1314. [DOI] [PubMed] [Google Scholar]
  • 2.Ateev M, Kristin R, Brockmeyer DM et al (2020) Rapidly converting to “virtual practices”: outpatient care in the era of Covid-19. Catalyst non-issue content 1. 10.1056/CAT.20.0091
  • 3.Greenhalgh T, Koh GCH, Car J. Covid-19: a remote assessment in primary care. BMJ. 2020;368:m1182. doi: 10.1136/bmj.m1182. [DOI] [PubMed] [Google Scholar]
  • 4.Hollander JE, Carr BG. Virtually perfect? telemedicine for Covid-19. N Engl J Med. 2020 doi: 10.1056/NEJMp2003539. [DOI] [PubMed] [Google Scholar]
  • 5.Hatcher-Martin JM, Adams JL, Anderson ER, et al. Telemedicine in neurology: telemedicine work group of the American Academy of Neurology update. Neurology. 2020;94:30–38. doi: 10.1212/WNL.0000000000008708. [DOI] [PubMed] [Google Scholar]
  • 6.Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020 doi: 10.1212/WNL.0000000000009566. [DOI] [PubMed] [Google Scholar]
  • 7.Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (phase III) J Neurol Sci. 1999;169:13–21. doi: 10.1016/s0022-510x(99)00210-5. [DOI] [PubMed] [Google Scholar]
  • 8.Wolfe GI, Herbelin L, Nations SP, et al. Myasthenia gravis activities of daily living profile. Neurology. 1999;52:1487–1489. doi: 10.1212/wnl.52.7.1487. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology are provided here courtesy of Nature Publishing Group

RESOURCES